Genus plc
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as techni… Read more
Genus plc (GENSY) - Total Assets
Latest total assets as of December 2025: $921.30 Million USD
Based on the latest financial reports, Genus plc (GENSY) holds total assets worth $921.30 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Genus plc - Total Assets Trend (2020–2025)
This chart illustrates how Genus plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Genus plc - Asset Composition Analysis
Current Asset Composition (June 2025)
Genus plc's total assets of $921.30 Million consist of 28.3% current assets and 71.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.3% |
| Accounts Receivable | $83.60 Million | 9.3% |
| Inventory | $80.90 Million | 9.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $55.30 Million | 6.2% |
| Goodwill | $102.80 Million | 11.4% |
Asset Composition Trend (2020–2025)
This chart illustrates how Genus plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Genus plc's current assets represent 28.3% of total assets in 2025, an increase from 26.2% in 2020.
- Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, up from 4.8% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, a decrease from 19.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 11.4% of total assets.
Genus plc Competitors by Total Assets
Key competitors of Genus plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Genus plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Genus plc generates 0.75x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Genus plc generates $ 2.15 in net profit.
Genus plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.25 | 1.94 | 2.03 |
| Quick Ratio | 1.70 | 1.33 | 1.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $169.10 Million | $ 126.70 Million | $ 137.80 Million |
Genus plc - Advanced Valuation Insights
This section examines the relationship between Genus plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.66 |
| Latest Market Cap to Assets Ratio | 1.92 |
| Asset Growth Rate (YoY) | -9.0% |
| Total Assets | $899.00 Million |
| Market Capitalization | $1.73 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Genus plc's assets above their book value (1.92 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Genus plc's assets decreased by 9.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Genus plc (2020–2025)
The table below shows the annual total assets of Genus plc from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $899.00 Million | -8.99% |
| 2024-06-30 | $987.80 Million | -1.96% |
| 2023-06-30 | $1.01 Billion | -1.02% |
| 2022-06-30 | $1.02 Billion | +19.61% |
| 2021-06-30 | $851.00 Million | -0.51% |
| 2020-06-30 | $855.40 Million | -- |